These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2151370

  • 1. [Electrocardiographic and echocardiographic changes during antihypertensive therapy].
    Sau F, Seguro C, Pili G, Basciu M, Siddi PP, Tamponi R, Cherchi A.
    Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370
    [Abstract] [Full Text] [Related]

  • 2. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F, Seguro C, Pargentino E.
    Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
    [Abstract] [Full Text] [Related]

  • 3. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
    Cherchi A, Sau F, Seguro C.
    J Clin Hypertens; 1987 Jun; 3(2):216-25. PubMed ID: 2886561
    [Abstract] [Full Text] [Related]

  • 4. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE, Froeland G, Wasenius AK, Knutsen KM, Michelsen S, Stugaard M.
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [Abstract] [Full Text] [Related]

  • 5. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 6. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F, Seguro C, Lai C, Orani E, Soro A, Onnis E, Cherchi A.
    Cardiologia; 1990 Nov 12; 35(11):925-30. PubMed ID: 2151570
    [Abstract] [Full Text] [Related]

  • 7. [The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].
    Sau F, Seguro C, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A.
    Cardiologia; 1993 Jun 12; 38(6):369-76. PubMed ID: 8402746
    [Abstract] [Full Text] [Related]

  • 8. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 9. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct 28; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 10. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May 28; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 11. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 May 28; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 12. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
    Okin PM, Devereux RB, Liu JE, Oikarinen L, Jern S, Kjeldsen SE, Julius S, Wachtell K, Nieminen MS, Dahlöf B.
    J Hum Hypertens; 2004 Jun 28; 18(6):403-9. PubMed ID: 15057252
    [Abstract] [Full Text] [Related]

  • 13. Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy?
    Hamada M, Ohtani T, Suzuki M, Lin M, Kobayashi T, Okayama H, Takezaki M, Hashida K, Abe M, Matsuoka H.
    J Cardiol; 1993 Jun 28; 23(2):165-75. PubMed ID: 8176628
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M, Korzeniowska B, Tendera M.
    Int J Cardiol; 2006 Jan 26; 106(3):382-9. PubMed ID: 15996771
    [Abstract] [Full Text] [Related]

  • 15. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 Jan 26; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic administration of the fixed combination slow-release oxprenolol-chlorthalidone on left ventricular hypertrophy in hypertensive patients. Echocardiographic study.
    Bertoni T, Alberti D, Peloso A, Francucci BM, De Ambroggi L.
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar 26; 26(3):148-52. PubMed ID: 2970442
    [Abstract] [Full Text] [Related]

  • 17. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D.
    Z Kardiol; 1985 Mar 26; 74 Suppl 7():153-69. PubMed ID: 2936016
    [Abstract] [Full Text] [Related]

  • 18. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2006 Oct 26; 24(10):2079-84. PubMed ID: 16957569
    [Abstract] [Full Text] [Related]

  • 19. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
    Franz IW, Tönnesmann U, Behr U, Ketelhut R.
    Z Kardiol; 1989 Oct 26; 78 Suppl 5():43-8. PubMed ID: 2561036
    [Abstract] [Full Text] [Related]

  • 20. Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population.
    Devereux RB, Casale PN, Hammond IW, Savage DD, Alderman MH, Campo E, Alonso DR, Laragh JH.
    J Clin Hypertens; 1987 Mar 26; 3(1):66-78. PubMed ID: 2952768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.